Why Moderna's stock is falling after Merck's Covid pill announcement

Steve Weiss, Short Hills Capital managing partner, joins 'The Halftime Report' to discuss Moderna's stock, which he is heavily invested in. "This is absolutely ridiculous," he tells Scott Wapner as he tries to understand why Moderna's stock is falling after Merck's announcement that they're looking for emergency authorization of a Covid antiviral drug.